Prostate cancer and race: variation in diagnosis and treatment
- PMID: 14521652
- PMCID: PMC1494936
- DOI: 10.1046/j.1525-1497.2003.30801.x
Prostate cancer and race: variation in diagnosis and treatment
Comment on
-
A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test.J Gen Intern Med. 2003 Oct;18(10):781-7. doi: 10.1046/j.1525-1497.2003.20911.x. J Gen Intern Med. 2003. PMID: 14521639 Free PMC article. Clinical Trial.
-
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.J Gen Intern Med. 2003 Oct;18(10):845-53. doi: 10.1046/j.1525-1497.2003.21105.x. J Gen Intern Med. 2003. PMID: 14521648 Free PMC article.
References
-
- Barry MJ. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med. 2001;344:1373–7. - PubMed
-
- Fowler FJ, McNaughton Collins M, Albertsen P, et al. Comparisons of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000;283:3217–22. - PubMed
-
- Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996;11:342–9. - PubMed